Laclarée, a pioneering company in Villeurbanne, France, has successfully raised €3.5 million in equity Seed funding to advance its innovative adaptive eyeglasses designed for presbyopia correction. The investment, led by Rimonci Capital and supported by existing investors such as UI-Investissement and HTGF, underscores the growing demand for breakthrough technologies in vision care. The funding will accelerate the development of Laclarée's first commercial product, with a launch projected for mid-2026. The technology aims to enhance the quality of life for the two billion individuals affected by presbyopia globally, by mimicking the natural autofocus ability of the eye.
We are thrilled to support Laclarée in bringing its breakthrough technology to new markets, setting a new standard for presbyopia correction worldwide.
This Seed round will be key for Laclarée to offer these customers the first commercial autofocussing eyeglass pair.
Collection
[
|
...
]